Immunotherapy to Hold 1/4th of the Global Pediatric Neuroblastoma Treatment Market Through 2030
The recent COVID-19 pandemic has stalled important businesses across the world, attributed to a shortage in workforce within organizations and increased work-from-home directives. A recent [read full press release…]